Sign in
4

Changes in Ownership

Protagonist Therapeutics, Inc Filed Acc 0001209191-20-014092

Options or other derivatives

  • Chief Scientific Officer acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Liu David Y · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-28 Grant or award : show line 1 in the form Stock Option (right to buy) +70,000 70,000 D
Loading xslF345X03/doc4.xml…